Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

InMed Pharmaceuticals Inc. (INM)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsJun-30-23Jun-30-22Jun-30-21Jun-30-20Jun-30-19Jun-30-18
   10-K10-K10-K10-KS-1S-1/A
Sales  5.51.11.9   
            Sales growth  405.0%-42.8%    
Cost of sales  2.40.5    
   
Inventory write-down        
    Gross profit  1.40.5    
            Gross margin  25.5%49.9%    
   
Operating Expenses        
Research and development and patents  3.77.35.35.8  
General and administrative  5.86.94.53.24,296.56.1
Amortization and depreciation  0.20.20.10.1119.40.1
Impairment of intangible assets and goodwill   3.5    
    Total operating expenses  20.635.99.99.24,415.96.2
   
Other Income (Expense)        
Interest and other income  0.50.10.00.1  
Warrant modification expense   -1.3    
   
Foreign exchange loss        
    Loss before income tax expense  -7.9-18.6    
Income tax expense  0.0     
    Net loss for the year  -7.9-18.6-10.2-8.9-9,248.5-8.0
   
Net loss per share for the year        
Basic and diluted (in Dollars per share)  ($3.25)($33.17)($37.96)($1.71)($1.78)($1.86)
   
Weighted average outstanding common shares        
Basic and diluted (in Shares)  2.40.60.35.25.24.3

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy